Autoimmune hepatitis and Weakness

Summary:

Weakness is found among people with Autoimmune hepatitis, especially for people who are female, 60+ old.

The study analyzes which people have Weakness with Autoimmune hepatitis. It is created by eHealthMe based on reports of 58 people who have Autoimmune hepatitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Autoimmune hepatitis?

Autoimmune hepatitis is found to be associated with 580 drugs and 820 conditions by eHealthMe. Check the latest studies of Autoimmune hepatitis.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

58 people who have Autoimmune Hepatitis and Weakness are studied.

Would you have Weakness when you have Autoimmune hepatitis?

Gender of people who have Autoimmune Hepatitis and experienced Weakness *:

  • female: 69.09 %
  • male: 30.91 %

Age of people who have Autoimmune Hepatitis and experienced Weakness *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 17.02 %
  • 20-29: 0.0 %
  • 30-39: 10.64 %
  • 40-49: 10.64 %
  • 50-59: 12.77 %
  • 60+: 48.94 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 7 people, 12.07%
  2. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 10.34%
  3. Diabetes: 4 people, 6.90%
  4. Pain: 4 people, 6.90%
  5. Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 5.17%
  6. Hepatitis C: 3 people, 5.17%
  7. Depression: 3 people, 5.17%
  8. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 3.45%
  9. High Blood Cholesterol: 2 people, 3.45%
  10. Type 1 Diabetes: 2 people, 3.45%

Common drugs taken by these people *:

  1. Imuran: 10 people, 17.24%
  2. Cellcept: 10 people, 17.24%
  3. Azathioprine: 8 people, 13.79%
  4. Prednisone: 7 people, 12.07%
  5. Accutane: 6 people, 10.34%
  6. Asacol: 6 people, 10.34%
  7. Cipro: 6 people, 10.34%
  8. Demerol: 6 people, 10.34%
  9. Tegretol: 6 people, 10.34%
  10. Paracetamol: 6 people, 10.34%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 20 people, 34.48%
  2. Stress And Anxiety: 20 people, 34.48%
  3. Thrombocytopenia (decrease of platelets in blood): 14 people, 24.14%
  4. Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 13 people, 22.41%
  5. Dyspnea (difficult or laboured breathing): 12 people, 20.69%
  6. Head Injury: 11 people, 18.97%
  7. Weight Decreased: 11 people, 18.97%
  8. Pain: 11 people, 18.97%
  9. Oedema Peripheral (superficial swelling): 10 people, 17.24%
  10. Fall: 10 people, 17.24%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weakness?

- Check whether Weakness is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Weakness:

All the conditions that are associated with Weakness:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weakness and Autoimmune hepatitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: